Fabric.AI, Inc. (Nasdaq: FABC) is a fabless semiconductor company developing MicroLED-based optical interconnects designed to ...

NAPC Defense, Inc. (OTCID: BLIS) ("NAPC Defense" or the "Company"), a U.S.-licensed defense manufacturer with exclusive ...

STARTRADER has added SPCX CFD (Space Exploration Technologies Corp.) to its trading platform, making the instrument available ...

The Dexterra Group cleaning contractor employing workers at the Greater Vancouver SkyTrain line are falling short and TransLink needs to take action, said SEIU Local 2 at a TransLink Board Meeting ...

Enerpac Tool Group Corp. (NYSE: EPAC) announced today that it will release its third quarter fiscal 2026 earnings after the market closes on Tuesday, July 7, 2026. Management will conduct a conference ...

SNOWLINE GOLD CORP. (TSX: SGD) (OTCQB: SNWGF) (the “Company ” or “Snowline ”) is pleased to announce the results of voting at its Annual General and Special Meeting of Shareholders (“Meeting ”) held ...

Brookfield Infrastructure Corporation (the “Corporation”) (TSX, NYSE: BIPC) today announced that all nine nominees proposed for election to the board of directors by holders of class A exchangeable ...

BOISE, Idaho, June 24, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its third quarter of fiscal 2026, which ended May 28, 2026. Revenue of $41.46 billion ...

S&P Global Ratings has upgraded ratings on several subsidiaries of Freedom Holding Corp., a Nasdaq-listed international investment and technology group. The ratings on Freedom Finance JSC, Freedom ...

KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), an energy-systems platform company that enables the safe, certifiable deployment of ultra-high-power lithium battery ...

Charitable Impact today announced the launch of Introduction to Donor-Advised Funds, a CIRO-accredited continuing education (CE) course designed to teach financial advisors how to integrate charitable ...

Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment ...